Cerebral venous thrombosis and thrombophilia: A systematic review and meta-analysis

Seminars in Thrombosis and Hemostasis

Volumn 39, Issue 8, 2013, Pages 913-927

  Lauw, Mandy N ^a   Barco, Stefano ^a,b   Coutinho, Jonathan M ^a   Middeldorp, Saskia ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF PAVIA   (Italy)

Author keywords

cerebral venous thrombosis; meta analysis; sinus thrombosis; systematic review; thrombophilia

Indexed keywords

ANTITHROMBIN; BETA2 GLYCOPROTEIN 1 ANTIBODY; BLOOD CLOTTING FACTOR 5 LEIDEN; BLOOD CLOTTING FACTOR 8; CARDIOLIPIN ANTIBODY; HOMOCYSTEINE; JANUS KINASE 2; LUPUS ANTICOAGULANT; PHOSPHOLIPID ANTIBODY; PROTEIN C; PROTEIN S; PROTHROMBIN;

AMINO ACID BLOOD LEVEL; CEREBRAL SINUS THROMBOSIS; DISEASE ASSOCIATION; GENE MUTATION; GENETIC POLYMORPHISM; HUMAN; HYPERHOMOCYSTEINEMIA; PRIORITY JOURNAL; RECURRENT DISEASE; REVIEW; SYSTEMATIC REVIEW; THROMBOPHILIA; VENOUS THROMBOEMBOLISM;

CEREBRAL VEINS; HUMANS; ODDS RATIO; RISK FACTORS; STROKE; THROMBOPHILIA; VENOUS THROMBOEMBOLISM; VENOUS THROMBOSIS;

EID: 84887021473     PISSN: 00946176     EISSN: 10989064     Source Type: Journal    
DOI: 10.1055/s-0033-1357504     Document Type: Review

References (81)

1. Einhäupl K., Stam J., Bousser M. G., et al. European Federation of Neurological Societies. EFNS guideline on the treatment of cerebral venous and sinus thrombosis in adult patients. Eur J Neurol: 2010; 17 10 1229 1235
2. Stam J. Thrombosis of the cerebral veins and sinuses. N Engl J Med: 2005; 352 17 1791 1798
3. Bousser M. G., Ferro J. M. Cerebral venous thrombosis: an update. Lancet Neurol: 2007; 6 2 162 170 (Pubitemid 46097542)
4. Coutinho J. M., Zuurbier S. M., Aramideh M., Stam J. The incidence of cerebral venous thrombosis: a cross-sectional study. Stroke: 2012; 43 12 3375 3377
5. Coutinho J. M., Ferro J. M., Canhão P., et al. Cerebral venous and sinus thrombosis in women. Stroke: 2009; 40 7 2356 2361
6. Cantú C., Barinagarrementeria F. Cerebral venous thrombosis associated with pregnancy and puerperium. Review of 67 cases. Stroke: 1993; 24 12 1880 1884 (Pubitemid 23352719)
7. Heit J. A., Silverstein M. D., Mohr D. N., Petterson T. M., O'Fallon W. M., Melton L. J. III. Risk factors for deep vein thrombosis and pulmonary embolism: a population-based case-control study. Arch Intern Med: 2000; 160 6 809 815 (Pubitemid 30165241)
8. Vossen C. Y., Conard J., Fontcuberta J., et al. Familial thrombophilia and lifetime risk of venous thrombosis. J Thromb Haemost: 2004; 2 9 1526 1532 (Pubitemid 40186165)
9. Coppens M., Reijnders J. H., Middeldorp S., Doggen C. J., Rosendaal F. R. Testing for inherited thrombophilia does not reduce the recurrence of venous thrombosis. J Thromb Haemost: 2008; 6 9 1474 1477
10. Christiansen S. C., Cannegieter S. C., Koster T., Vandenbroucke J. P., Rosendaal F. R. Thrombophilia, clinical factors, and recurrent venous thrombotic events. JAMA: 2005; 293 19 2352 2361 (Pubitemid 40676757)
11. Bates S. M., Greer I. A., Middeldorp S., et al. American College of Chest Physicians. VTE, thrombophilia, antithrombotic therapy, and pregnancy: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest: 2012; 141 2 Suppl e691S e736S
12. Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol: 2010; 25 9 603 605
13. Sanderson S., Tatt I. D., Higgins J. P. Tools for assessing quality and susceptibility to bias in observational studies in epidemiology: a systematic review and annotated bibliography. Int J Epidemiol: 2007; 36 3 666 676 (Pubitemid 47244573)
14. Wells G. A., Shea B., O'Connell D., et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. http://www.ohri.ca/programs/clinical-epidemiology/oxford.asp. Accessed March 3, 2013
15. deVeber G., Andrew M., Adams C., et al. Canadian Pediatric Ischemic Stroke Study Group. Cerebral sinovenous thrombosis in children. N Engl J Med: 2001; 345 6 417 423 (Pubitemid 32747605)
16. Camargo E. C., Massaro A. R., Bacheschi L. A., et al. Ethnic differences in cerebral venous thrombosis. Cerebrovasc Dis: 2005; 19 3 147 151 (Pubitemid 40754331)
17. Terazzi E., Mittino D., Rudà R., et al. Cerebral Venous Thrombosis Group. Cerebral venous thrombosis: a retrospective multicentre study of 48 patients. Neurol Sci: 2005; 25 6 311 315 (Pubitemid 40347908)
18. Wasay M., Bakshi R., Bobustuc G., et al. Cerebral venous thrombosis: analysis of a multicenter cohort from the United States. J Stroke Cerebrovasc Dis: 2008; 17 2 49 54 (Pubitemid 351381440)
19. Coutinho J. M., Ferro J. M., Canhão P., et al. Cerebral venous and sinus thrombosis in women. Stroke: 2009; 40 7 2356 2361
20. Algahtani H. A., Abdu A. P., Shami A. M., et al. Cerebral venous sinus thrombosis in Saudi Arabia. Neurosciences (Riyadh): 2011; 16 4 329 334
21. Dentali F., Poli D., Scoditti U., et al. CErebral VEin Thrombosis International Study Investigators. Long-term outcomes of patients with cerebral vein thrombosis: a multicenter study. J Thromb Haemost: 2012; 10 7 1297 1302
22. Narayan D., Kaul S., Ravishankar K., et al. Risk factors, clinical profile, and long-term outcome of 428 patients of cerebral sinus venous thrombosis: insights from Nizam's Institute Venous Stroke Registry, Hyderabad (India). Neurol India: 2012; 60 2 154 159
23. Uzar E., Ekici F., Acar A., et al. Cerebral venous sinus thrombosis: an analyses of 47 patients. Eur Rev Med Pharmacol Sci: 2012; 16 11 1499 1505
24. Deschiens M. A., Conard J., Horellou M. H., et al. Coagulation studies, factor V Leiden, and anticardiolipin antibodies in 40 cases of cerebral venous thrombosis. Stroke: 1996; 27 10 1724 1730 (Pubitemid 26332493)
25. de Bruijn S. F., de Haan R. J., Stam J.; For The Cerebral Venous Sinus Thrombosis Study Group. Clinical features and prognostic factors of cerebral venous sinus thrombosis in a prospective series of 59 patients. J Neurol Neurosurg Psychiatry: 2001; 70 1 105 108 (Pubitemid 32096130)
26. Breteau G., Mounier-Vehier F., Godefroy O., et al. Cerebral venous thrombosis 3-year clinical outcome in 55 consecutive patients. J Neurol: 2003; 250 1 29 35 (Pubitemid 36206681)
27. Amberger N., Masuhr F., Valdueza J. M., Vetter B., Weih M. A negative personal and family history for venous thrombotic events is not sufficient to exclude thrombophilia in patients with cerebral venous thrombosis. Eur J Neurol: 2004; 11 8 555 558 (Pubitemid 39062095)
28. Stolz E., Rahimi A., Gerriets T., Kraus J., Kaps M. Cerebral venous thrombosis: an all or nothing disease? Prognostic factors and long-term outcome. Clin Neurol Neurosurg: 2005; 107 2 99 107 (Pubitemid 40228968)
29. De Stefano V., Fiorini A., Rossi E., et al. Incidence of the JAK2 V617F mutation among patients with splanchnic or cerebral venous thrombosis and without overt chronic myeloproliferative disorders. J Thromb Haemost: 2007; 5 4 708 714 (Pubitemid 46563568)
30. Bellucci S., Cassinat B., Bonnin N., Marzac C., Crassard I. The V617F JAK 2 mutation is not a frequent event in patients with cerebral venous thrombosis without overt chronic myeloproliferative disorder. Thromb Haemost: 2008; 99 6 1119 1120 (Pubitemid 351810496)
31. Zubkov A. Y., McBane R. D., Brown R. D., Rabinstein A. A. Brain lesions in cerebral venous sinus thrombosis. Stroke: 2009; 40 4 1509 1511
32. Alonso-Cánovas A., Masjuan J., González-Valcárcel J., et al. [Cerebral venous thrombosis: when etiology makes the difference]. Neurologia: 2009; 24 7 439 445
33. Martinelli I., Bucciarelli P., Passamonti S. M., Battaglioli T., Previtali E., Mannucci P. M. Long-term evaluation of the risk of recurrence after cerebral sinus-venous thrombosis. Circulation: 2010; 121 25 2740 2746
34. Aaron S., Alexander M., Maya T., et al. Underlying prothrombotic states in pregnancy associated cerebral venous thrombosis. Neurol India: 2010; 58 4 555 559
35. Yokus O., Sahin Balcik O., Albayrak M., et al. Evaluation of risk factors for thrombophilia in patients with cerebral venous thrombosis. Turk J Hematol: 2010; 27 162 167
36. Sanz Gallego I., Fuentes B., Martínez-Sánchez P., Díez Tejedor E. Do cerebral venous thrombosis risk factors influence the development of an associated venous infarction? Neurologia: 2011; 26 1 13 19
37. Passamonti S. M., Biguzzi E., Cazzola M., et al. The JAK2 V617F mutation in patients with cerebral venous thrombosis. J Thromb Haemost: 2012; 10 6 998 1003
38. Martinelli I., Landi G., Merati G., Cella R., Tosetto A., Mannucci P. M. Factor V gene mutation is a risk factor for cerebral venous thrombosis. Thromb Haemost: 1996; 75 3 393 394 (Pubitemid 26099700)
39. Zuber M., Toulon P., Marnet L., Mas J. L. Factor V Leiden mutation in cerebral venous thrombosis. Stroke: 1996; 27 10 1721 1723 (Pubitemid 26332492)
40. Lüdemann P., Nabavi D. G., Junker R., et al. Factor V Leiden mutation is a risk factor for cerebral venous thrombosis: a case-control study of 55 patients. Stroke: 1998; 29 12 2507 2510 (Pubitemid 28543998)
41. Hillier C. E., Collins P. W., Bowen D. J., Bowley S., Wiles C. M. Inherited prothrombotic risk factors and cerebral venous thrombosis. QJM: 1998; 91 10 677 680 (Pubitemid 28479298)
42. Weih M., Vetter B., Ziemer S., et al. Increased rate of factor V Leiden mutation in patients with cerebral venous thrombosis. J Neurol: 1998; 245 3 149 152 (Pubitemid 28135057)
43. Christopher R., Nagaraja D., Dixit N. S., Narayanan C. P. Anticardiolipin antibodies: a study in cerebral venous thrombosis. Acta Neurol Scand: 1999; 99 2 121 124 (Pubitemid 29064319)
44. Madonna P., De Stefano V., Coppola A., Albisinni R., Cerbone A. M. G20210A PRTH gene mutation and other trombophilic polymorphisms in patients with cerebral vein thrombosis. Stroke: 2000; 31 7 1787 1788 (Pubitemid 30437541)
45. Voetsch B., Damasceno B. P., Camargo E. C., et al. Inherited thrombophilia as a risk factor for the development of ischemic stroke in young adults. Thromb Haemost: 2000; 83 2 229 233 (Pubitemid 30093224)
46. Bombeli T., Basic A., Fehr J. Prevalence of hereditary thrombophilia in patients with thrombosis in different venous systems. Am J Hematol: 2002; 70 2 126 132
47. Bonduel M., Sciuccati G., Hepner M., et al. Factor V Leiden and prothrombin gene G20210A mutation in children with cerebral thromboembolism. Am J Hematol: 2003; 73 2 81 86 (Pubitemid 36578428)
48. Heller C., Heinecke A., Junker R., et al. Childhood Stroke Study Group. Cerebral venous thrombosis in children: a multifactorial origin. Circulation: 2003; 108 11 1362 1367 (Pubitemid 37174415)
49. Martinelli I., Battaglioli T., Pedotti P., Cattaneo M., Mannucci P. M. Hyperhomocysteinemia in cerebral vein thrombosis. Blood: 2003; 102 4 1363 1366 (Pubitemid 36988044)
50. Boncoraglio G., Carriero M. R., Chiapparini L., et al. Hyperhomocysteinemia and other thrombophilic risk factors in 26 patients with cerebral venous thrombosis. Eur J Neurol: 2004; 11 6 405 409 (Pubitemid 39272945)
51. Cantu C., Alonso E., Jara A., et al. Hyperhomocysteinemia, low folate and vitamin B12 concentrations, and methylene tetrahydrofolate reductase mutation in cerebral venous thrombosis. Stroke: 2004; 35 8 1790 1794 (Pubitemid 38971852)
52. Ventura P., Cobelli M., Marietta M., Panini R., Rosa M. C., Salvioli G. Hyperhomocysteinemia and other newly recognized inherited coagulation disorders (factor V Leiden and prothrombin gene mutation) in patients with idiopathic cerebral vein thrombosis. Cerebrovasc Dis: 2004; 17 2-3 153 159 (Pubitemid 38529191)
53. Tufano A., Coppola A., Varricchione N., et al. Predisposing factors in patients with early-onset cerebral vein thrombosis. Thromb Res: 2005; 115 5 439 440 (Pubitemid 40283490)
54. Kenet G., Waldman D., Lubetsky A., et al. Paediatric cerebral sinus vein thrombosis. A multi-center, case-controlled study. Thromb Haemost: 2004; 92 4 713 718 (Pubitemid 39386695)
55. Rodrigues C. A., Rocha L. K., Morelli V. M., Franco R. F., Lourenço D. M. Prothrombin G20210A mutation, and not factor V Leiden mutation, is a risk factor for cerebral venous thrombosis in Brazilian patients. J Thromb Haemost: 2004; 2 7 1211 1212 (Pubitemid 40186105)
56. Le Cam-Duchez V., Bagan-Triquenot A., Ménard J. F., Mihout B., Borg J. Y. Association of the protein C promoter CG haplotype and the factor II G20210A mutation is a risk factor for cerebral venous thrombosis. Blood Coagul Fibrinolysis: 2005; 16 7 495 500 (Pubitemid 41794944)
57. Gadelha T., André C., Jucá A. A., Nucci M. Prothrombin 20210A and oral contraceptive use as risk factors for cerebral venous thrombosis. Cerebrovasc Dis: 2005; 19 1 49 52 (Pubitemid 40082258)
58. Dindagur N., Kruthika-Vinod T. P., Christopher R. Thrombophilic gene polymorphisms in puerperal cerebral veno-sinus thrombosis. J Neurol Sci: 2006; 249 1 25 30 (Pubitemid 44665904)
59. Lichy C., Dong-Si T., Reuner K., et al. Risk of cerebral venous thrombosis and novel gene polymorphisms of the coagulation and fibrinolytic systems. J Neurol: 2006; 253 3 316 320
60. Bugnicourt J. M., Roussel B., Tramier B., Lamy C., Godefroy O. Cerebral venous thrombosis and plasma concentrations of factor VIII and von Willebrand factor: a case control study. J Neurol Neurosurg Psychiatry: 2007; 78 7 699 701 (Pubitemid 46998838)
61. Colaizzo D., Amitrano L., Iannaccone L., et al. Gain-of-function gene mutations and venous thromboembolism: distinct roles in different clinical settings. J Med Genet: 2007; 44 6 412 416 (Pubitemid 46953726)
62. Stolz E., Valdueza J. M., Grebe M., et al. Anemia as a risk factor for cerebral venous thrombosis? An old hypothesis revisited. Results of a prospective study. J Neurol: 2007; 254 6 729 734 (Pubitemid 47012446)
63. Cesarman-Maus G., Cantú-Brito C., Barinagarrementeria F., et al. Autoantibodies against the fibrinolytic receptor, annexin A2, in cerebral venous thrombosis. Stroke: 2011; 42 2 501 503
64. Laugesaar R., Kahre T., Kolk A., Uustalu U., Kool P., Talvik T. Factor V Leiden and prothrombin 20210G>A [corrected] mutation and paediatric ischaemic stroke: a case-control study and two meta-analyses. Acta Paediatr: 2010; 99 8 1168 1174
65. Rahimi Z., Mozafari H., Bigvand A. H., et al. Cerebral venous and sinus thrombosis and thrombophilic mutations in Western Iran: association with factor V Leiden. Clin Appl Thromb Hemost: 2010; 16 4 430 434
66. Ringelstein M., Jung A., Berger K., et al. Promotor polymorphisms of plasminogen activator inhibitor-1 and other thrombophilic genotypes in cerebral venous thrombosis: a case-control study in adults. J Neurol: 2012; 259 11 2287 2292
67. Ashjazadeh N., Poursadeghfard M., Farjadian S. Factor V G1691A and prothrombin G20210A gene polymorphisms among Iranian patients with cerebral venous thrombosis. Neurol Asia: 2012; 17 3 199 203
68. Ben Salem-Berrabah O., Fekih-Mrissa N., N'siri B., et al. Thrombophilic polymorphisms - factor V Leiden G1691A, prothrombin G20210A and MTHFR C677T - in Tunisian patients with cerebral venous thrombosis. J Clin Neurosci: 2012; 19 9 1326 1327
69. Libourel E. J., ten Kate M. K., Brouwer J. L., Veeger N. J., van der Meer J. Contribution of multiple thrombophilic and transient risk factors in the development of cerebral venous thrombosis. Thromb Res: 2007; 121 3 301 307
70. Wysokinska E. M., Wysokinski W. E., Brown R. D., et al. Thrombophilia differences in cerebral venous sinus and lower extremity deep venous thrombosis. Neurology: 2008; 70 8 627 633 (Pubitemid 351294640)
71. Martinelli I., Sacchi E., Landi G., Taioli E., Duca F., Mannucci P. M. High risk of cerebral-vein thrombosis in carriers of a prothrombin-gene mutation and in users of oral contraceptives. N Engl J Med: 1998; 338 25 1793 1797 (Pubitemid 28277959)
72. Girot M., Ferro J. M., Canhão P., et al. ISCVT Investigators. Predictors of outcome in patients with cerebral venous thrombosis and intracerebral hemorrhage. Stroke: 2007; 38 2 337 342 (Pubitemid 46184304)
73. Gosk-Bierska I., Wysokinski W., Brown R. D. Jr., et al. Cerebral venous sinus thrombosis: Incidence of venous thrombosis recurrence and survival. Neurology: 2006; 67 5 814 819 (Pubitemid 44394195)
74. Dentali F., Crowther M., Ageno W. Thrombophilic abnormalities, oral contraceptives, and risk of cerebral vein thrombosis: a meta-analysis. Blood: 2006; 107 7 2766 2773
75. Kenet G., Lütkhoff L. K., Albisetti M., et al. Impact of thrombophilia on risk of arterial ischemic stroke or cerebral sinovenous thrombosis in neonates and children: a systematic review and meta-analysis of observational studies. Circulation: 2010; 121 16 1838 1847
76. Dayan N., Holcroft C. A., Tagalakis V. The risk of venous thrombosis, including cerebral vein thrombosis, among women with thrombophilia and oral contraceptive use: a meta-analysis. Clin Appl Thromb Hemost: 2011; 17 6 E141 E152
77. Marjot T., Yadav S., Hasan N., Bentley P., Sharma P. Genes associated with adult cerebral venous thrombosis. Stroke: 2011; 42 4 913 918
78. Bloemenkamp K. W., Rosendaal F. R., Helmerhorst F. M., Vandenbroucke J. P. Higher risk of venous thrombosis during early use of oral contraceptives in women with inherited clotting defects. Arch Intern Med: 2000; 160 1 49 52 (Pubitemid 30040972)
79. de Bruijn S. F., Stam J., Koopman M. M., Vandenbroucke J. P.; The Cerebral Venous Sinus Thrombosis Study Group Case-control study of risk of cerebral sinus thrombosis in oral contraceptive users and in [correction of who are] carriers of hereditary prothrombotic conditions. BMJ: 1998; 316 7131 589 592 (Pubitemid 28120990)
80. Cohn D. M., Vansenne F., de Borgie C. A., Middeldorp S. Thrombophilia testing for prevention of recurrent venous thromboembolism. Cochrane Database Syst Rev: 2012; 12 CD007069
81. Junker R., Nabavi D. G., Wolff E., et al. Plasminogen activator inhibitor-1 4G/4G-genotype is associated with cerebral sinus thrombosis in factor V Leiden carriers. Thromb Haemost: 1998; 80 4 706 707 (Pubitemid 28479367)